Inventory Summary of Qiagen N.V.

Qiagen N.V.'s latest annual inventory in 2023 was 398.38 Million USD , up 11.29% from previous year.
Qiagen N.V.'s latest quarterly inventory in 2024 Q2 was 321.75 Million USD , down -19.91% from previous quarter.
Qiagen N.V. reported annual inventory of 357.96 Million USD in 2022, up 9.29% from previous year.
Qiagen N.V. reported annual inventory of 327.52 Million USD in 2021, up 12.48% from previous year.
Qiagen N.V. reported quarterly inventory of 321.75 Million USD for 2024 Q2, down -19.91% from previous quarter.
Qiagen N.V. reported quarterly inventory of 398.38 Million USD for 2023 FY, up 11.29% from previous quarter.

Annual Inventory Chart of Qiagen N.V. (2023 - 1995)

Historical Annual Inventory of Qiagen N.V. (2023 - 1995)

Year	Inventory	Inventory Growth
2023	398.38 Million USD	11.29%
2022	357.96 Million USD	9.29%
2021	327.52 Million USD	12.48%
2020	291.18 Million USD	70.58%
2019	170.7 Million USD	4.78%
2018	162.91 Million USD	4.48%
2017	155.92 Million USD	14.19%
2016	136.55 Million USD	-0.02%
2015	136.58 Million USD	3.26%
2014	132.27 Million USD	3.26%
2013	128.09 Million USD	-5.32%
2012	135.29 Million USD	2.31%
2011	132.23 Million USD	4.42%
2010	126.63 Million USD	-3.22%
2009	130.85 Million USD	20.53%
2008	108.56 Million USD	22.88%
2007	88.34 Million USD	37.86%
2006	64.08 Million USD	19.44%
2005	53.65 Million USD	-10.82%
2004	60.16 Million USD	-7.67%
2003	65.16 Million USD	16.12%
2002	56.11 Million USD	76.0%
2001	31.88 Million USD	10.33%
2000	28.89 Million USD	28.45%
1999	22.49 Million USD	13.06%
1998	19.9 Million USD	36.3%
1997	14.6 Million USD	47.47%
1996	9.9 Million USD	59.68%
1995	6.2 Million USD	0.0%

Year	Inventory	Inventory Growth
2024 Q1	401.74 Million USD	0.84%
2024 Q2	321.75 Million USD	-19.91%
2023 FY	398.38 Million USD	11.29%
2023 Q3	399.2 Million USD	1.84%
2023 Q4	398.38 Million USD	-0.21%
2023 Q1	380.82 Million USD	6.39%
2023 Q2	391.98 Million USD	2.93%
2022 Q4	357.96 Million USD	10.66%
2022 Q2	322.83 Million USD	0.38%
2022 FY	357.96 Million USD	9.29%
2022 Q1	321.62 Million USD	-1.8%
2022 Q3	323.47 Million USD	0.2%
2021 Q3	335.69 Million USD	-1.57%
2021 Q4	327.52 Million USD	-2.43%
2021 FY	327.52 Million USD	12.48%
2021 Q1	316.28 Million USD	8.62%
2021 Q2	341.04 Million USD	7.83%
2020 Q3	254.64 Million USD	25.56%
2020 Q4	291.18 Million USD	14.35%
2020 Q2	202.8 Million USD	19.76%
2020 Q1	169.34 Million USD	-0.8%
2020 FY	291.18 Million USD	70.58%
2019 Q1	167.09 Million USD	2.57%
2019 Q2	169.52 Million USD	1.45%
2019 Q3	168.26 Million USD	-0.74%
2019 Q4	170.7 Million USD	1.45%
2019 FY	170.7 Million USD	4.78%
2018 Q2	158.23 Million USD	-1.22%
2018 Q1	160.19 Million USD	2.74%
2018 FY	162.91 Million USD	4.48%
2018 Q4	162.91 Million USD	1.84%
2018 Q3	159.96 Million USD	1.1%
2017 Q4	155.92 Million USD	-3.72%
2017 FY	155.92 Million USD	14.19%
2017 Q3	161.94 Million USD	4.03%
2017 Q2	155.66 Million USD	8.08%
2017 Q1	144.03 Million USD	5.48%
2016 Q2	140.09 Million USD	-5.72%
2016 FY	136.55 Million USD	-0.02%
2016 Q1	148.59 Million USD	8.79%
2016 Q4	136.55 Million USD	-5.64%
2016 Q3	144.71 Million USD	3.3%
2015 FY	136.58 Million USD	3.26%
2015 Q1	136.09 Million USD	2.88%
2015 Q3	134.07 Million USD	-3.15%
2015 Q4	136.58 Million USD	1.87%
2015 Q2	138.43 Million USD	1.73%
2014 Q4	132.27 Million USD	0.57%
2014 FY	132.27 Million USD	3.26%
2014 Q3	131.52 Million USD	-3.13%
2014 Q2	135.77 Million USD	1.77%
2014 Q1	133.41 Million USD	4.15%
2013 Q3	143.15 Million USD	7.92%
2013 Q4	128.09 Million USD	-10.52%
2013 FY	128.09 Million USD	-5.32%
2013 Q1	130.64 Million USD	-3.44%
2013 Q2	132.64 Million USD	1.53%
2012 Q1	134.35 Million USD	1.6%
2012 FY	135.29 Million USD	2.31%
2012 Q3	143.17 Million USD	2.57%
2012 Q4	135.29 Million USD	-5.5%
2012 Q2	139.58 Million USD	3.89%
2011 Q1	132.75 Million USD	4.83%
2011 Q3	145.53 Million USD	4.42%
2011 Q4	132.23 Million USD	-9.14%
2011 FY	132.23 Million USD	4.42%
2011 Q2	139.36 Million USD	4.98%
2010 Q4	126.63 Million USD	-3.51%
2010 Q3	131.24 Million USD	11.41%
2010 FY	126.63 Million USD	-3.22%
2010 Q2	117.8 Million USD	-5.84%
2010 Q1	125.11 Million USD	-4.38%
2009 Q4	130.85 Million USD	-2.07%
2009 Q1	110.08 Million USD	1.41%
2009 Q2	120.11 Million USD	9.1%
2009 Q3	133.61 Million USD	11.25%
2009 FY	130.85 Million USD	20.53%
2008 Q3	113.73 Million USD	5.54%
2008 Q4	108.56 Million USD	-4.55%
2008 FY	108.56 Million USD	22.88%
2008 Q1	99.09 Million USD	12.17%
2008 Q2	107.76 Million USD	8.75%
2007 FY	88.34 Million USD	37.86%
2007 Q3	86.94 Million USD	29.31%
2007 Q4	88.34 Million USD	1.61%
2007 Q1	66.33 Million USD	3.51%
2007 Q2	67.23 Million USD	1.36%
2006 Q2	58.18 Million USD	6.71%
2006 Q4	64.08 Million USD	8.04%
2006 FY	64.08 Million USD	19.44%
2006 Q1	54.52 Million USD	1.63%
2006 Q3	59.31 Million USD	1.94%
2005 Q1	54.54 Million USD	-9.35%
2005 Q3	50.29 Million USD	2.0%
2005 FY	53.65 Million USD	-10.82%
2005 Q4	53.65 Million USD	6.67%
2005 Q2	49.31 Million USD	-9.59%
2004 Q4	60.16 Million USD	4.66%
2004 FY	60.16 Million USD	-7.67%
2004 Q2	57.75 Million USD	-14.01%
2004 Q3	57.48 Million USD	-0.47%
2004 Q1	67.16 Million USD	3.08%
2003 Q1	61.12 Million USD	8.92%
2003 FY	65.16 Million USD	16.12%
2003 Q3	63.65 Million USD	1.12%
2003 Q4	65.16 Million USD	2.37%
2003 Q2	62.94 Million USD	2.99%
2002 FY	56.11 Million USD	76.0%
2002 Q2	46.14 Million USD	29.85%
2002 Q1	35.53 Million USD	11.45%
2002 Q3	49.9 Million USD	8.15%
2002 Q4	56.11 Million USD	12.44%
2001 Q4	31.88 Million USD	-1.39%
2001 Q3	32.33 Million USD	8.44%
2001 Q2	29.81 Million USD	-0.2%
2001 Q1	29.87 Million USD	3.38%
2001 FY	31.88 Million USD	10.33%
2000 Q3	26.39 Million USD	4.94%
2000 Q1	22.27 Million USD	-1.0%
2000 FY	28.89 Million USD	28.45%
2000 Q4	28.89 Million USD	9.51%
2000 Q2	25.14 Million USD	12.9%
1999 Q2	17.2 Million USD	-4.44%
1999 Q3	20.68 Million USD	20.28%
1999 Q4	22.49 Million USD	8.75%
1999 FY	22.49 Million USD	13.06%
1999 Q1	18 Million USD	-9.55%
1998 Q4	19.9 Million USD	10.56%
1998 Q3	18 Million USD	13.21%
1998 Q1	14.9 Million USD	2.05%
1998 FY	19.9 Million USD	36.3%
1998 Q2	15.9 Million USD	6.71%
1997 Q1	10.6 Million USD	7.07%
1997 Q2	11.4 Million USD	7.55%
1997 FY	14.6 Million USD	47.47%
1997 Q3	12.4 Million USD	8.77%
1997 Q4	14.6 Million USD	17.74%
1996 FY	9.9 Million USD	59.68%
1996 Q4	9.9 Million USD	0.0%
1996 Q1	6.7 Million USD	0.0%
1995 FY	6.2 Million USD	0.0%

Peer Inventory Comparison of Qiagen N.V.

Name	Inventory	Inventory Difference
Agilent Technologies, Inc.	1.03 Billion USD	61.359%
Charles River Laboratories International, Inc.	380.25 Million USD	-4.767%
Quest Diagnostics Incorporated	190 Million USD	-109.676%
Danaher Corporation	2.59 Billion USD	84.642%
Enzo Biochem, Inc.	6.83 Million USD	-5731.162%
IQVIA Holdings Inc.	- USD	-Infinity%
Laboratory Corporation of America Holdings	474.6 Million USD	16.059%
Mettler-Toledo International Inc.	385.86 Million USD	-3.245%
Revvity, Inc.	428.06 Million USD	6.933%
Thermo Fisher Scientific Inc.	5.08 Billion USD	92.17%
Waters Corporation	516.23 Million USD	22.829%

Global Stocks Search

Qiagen N.V. (QGEN)

Inventory Summary of Qiagen N.V.

Annual Inventory Chart of Qiagen N.V. (2023 - 1995)

Historical Annual Inventory of Qiagen N.V. (2023 - 1995)

Peer Inventory Comparison of Qiagen N.V.